These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11170636)

  • 41. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
    Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
    Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM
    J Antimicrob Chemother; 2002 Dec; 50(6):833-8. PubMed ID: 12461001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in the development of P-gp inhibitors.
    Baumert C; Hilgeroth A
    Anticancer Agents Med Chem; 2009 May; 9(4):415-36. PubMed ID: 19442042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus.
    Stermitz FR; Scriven LN; Tegos G; Lewis K
    Planta Med; 2002 Dec; 68(12):1140-1. PubMed ID: 12494348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1.
    Rullo M; Niso M; Pisani L; Carrieri A; Colabufo NA; Cellamare S; Altomare CD
    Eur J Med Chem; 2019 Jan; 161():433-444. PubMed ID: 30384046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps.
    German N; Wei P; Kaatz GW; Kerns RJ
    Eur J Med Chem; 2008 Nov; 43(11):2453-63. PubMed ID: 18358571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery.
    Hsieh PC; Siegel SA; Rogers B; Davis D; Lewis K
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6602-6. PubMed ID: 9618458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump.
    Zhang L; Ma S
    ChemMedChem; 2010 Jun; 5(6):811-22. PubMed ID: 20373322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F; Héquet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    Eur J Med Chem; 2015 May; 95():185-98. PubMed ID: 25817769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum.
    Kakarla P; Floyd J; Mukherjee M; Devireddy AR; Inupakutika MA; Ranweera I; Kc R; 'Shrestha U; Cheeti UR; Willmon TM; Adams J; Bruns M; Gunda SK; Varela MF
    Arch Microbiol; 2017 Apr; 199(3):465-474. PubMed ID: 27830269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance.
    Bois F; Boumendjel A; Mariotte AM; Conseil G; Di Petro A
    Bioorg Med Chem; 1999 Dec; 7(12):2691-5. PubMed ID: 10658573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In search of natural substrates and inhibitors of MDR pumps.
    Lewis K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):247-54. PubMed ID: 11321580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria.
    Belofsky G; Percivill D; Lewis K; Tegos GP; Ekart J
    J Nat Prod; 2004 Mar; 67(3):481-4. PubMed ID: 15043439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A; Felicetti T; Iraci N; Manfroni G; Massari S; Pietrella D; Tabarrini O; Kaatz GW; Barreca ML; Sabatini S; Cecchetti V
    J Med Chem; 2017 Feb; 60(4):1598-1604. PubMed ID: 28117588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
    Takanaga H; Ohnishi A; Yamada S; Matsuo H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    J Pharmacol Exp Ther; 2000 Apr; 293(1):230-6. PubMed ID: 10734174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein.
    Maitrejean M; Comte G; Barron D; El Kirat K; Conseil G; Di Pietro A
    Bioorg Med Chem Lett; 2000 Jan; 10(2):157-60. PubMed ID: 10673101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flavonoids from Praxelis clematidea R.M. King and Robinson modulate bacterial drug resistance.
    Maia GL; Falcão-Silva Vdos S; Aquino PG; de Araújo-Júnior JX; Tavares JF; da Silva MS; Rodrigues LC; de Siqueira-Júnior JP; Barbosa-Filho JM
    Molecules; 2011 Jun; 16(6):4828-35. PubMed ID: 21666549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
    Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
    Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.